On the evening of December 13, Guangdong Jiaying Pharmaceutical announced that the company's Chairman Li Neng proposed to use its own funds to repurchase a portion of the company's issued ordinary shares (A shares) through the centralized bidding method on the Shenzhen Stock Exchange trading system. The repurchased shares are intended for the implementation of the employee stock ownership plan or Stock-based Incentive. According to the content of the proposal, combined with the company's financial and operational situation, the number of shares to be repurchased is to be no less than 7 million shares (inclusive), approximately accounting for 1.3793% of the company's total share capital; and no more than 13.5 million shares (inclusive), approximately accounting for 2.6600% of the company's total share capital. Based on the upper limit of 13.5 million shares (inclusive) and the upper limit of the repurchase price of 9.80 yuan/share (inclusive), the total amount for the repurchased shares does not exceed 132.3 million yuan (inclusive).